000 02202cam  2200409zi 4500
0019.913162
003CaOODSP
00520221101090033
006m     o  d f      
007cr mn|||||||||
008220708e202209  onca    ob   f000 0 eng d
020 |a9780660444864
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP5-140/2022E-PDF
24500|aSupplemental statement - recombinant influenza vaccines : |bCanadian immunization guide chapter on influenza and statement on seasonal influenza vaccine for 2022-2023.
24617|aSupplemental statement - quadrivalent recombinant influenza vaccines
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cSeptember 2022.
264 4|c©2022
300 |a1 online resource (57 pages) : |billustration
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Déclaration supplémentaire - vaccins antigrippaux recombinants : chapitre sur la grippe du guide canadien d'immunisation et déclaration sur la vaccination antigrippale pour la saison 2022-2023.
500 |aCover title.
500 |aOn cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI).
500 |a"Pub.: 220317."
500 |aIssued also in HTML format.
504 |aIncludes bibliographical references (pages 51-54).
650 0|aInfluenza vaccines|zCanada.
650 0|aInfluenza vaccines|xGovernment policy|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
7101 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body.
77508|tDéclaration supplémentaire - vaccins antigrippaux recombinants : |w(CaOODSP)9.913163
85640|qPDF|s929 KB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP5-140-2022-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/vaccines-immunization/recombinant-influenza-vaccines-supplemental-statement-canadian-immunization-guide-seasonal-influenza-vaccine-2022-2023.html